Lumida
/LMND
⌘K
Lemonade Inc

Lemonade Inc

LMND
$53.42USD+0.53%+0.28 today

MARKET CAP

4.1B

P/E (TTM)

FWD P/E

DAY RANGE

$53 – $53

52W RANGE

$46
$100

AI Summary

Stalk
TrimMedium

LMND is entrenched in a Stage 4 decline, trading below its flattening 9- and 20-day EMAs and well under the 200-day SMA. Medium-term bias remains bearish, and short-term conditions offer no clear exit trigger. We will trim into rallies toward the falling EMAs and prior resistance zones, while watching for any sustained reclaim of key averages.

  • Q2 2026 revenue +79% YoY to $294M; in-force premiums rose 32.5% to $1.43B.
  • Adjusted EBITDA loss narrowed to $19M; first positive quarter targeted in Q4 2026.
  • Operating expenses climbed 41% YoY to $182M, pressuring margin recovery.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Lemonade, Inc. (NYSE: LMND) operates as a technology-driven insurance company focused on disrupting the traditional insurance market with a digital-first approach. Utilizing advanced artificial intelligence, Lemonade offers a variety of insurance products, including renters, homeowners, and pet insurance. The company has seen rapid growth and expansion, particularly in the European market, and is also venturing into autonomous car insurance, positioning itself favorably within the emerging insurtech landscape by streamlining customer engagement and claims processing.

Bull says

  • Q2 2026 revenue +79% YoY to $294M; in-force premiums rose 32.5% to $1.43B.
  • Adjusted EBITDA loss narrowed to $19M; first positive quarter targeted in Q4 2026.
  • LAE ratio at 5% vs. 9% industry average shows AI-driven efficiency.
  • Autonomous car insurance launch and multi-state expansion boost cross-sell opportunity.
  • High earnings yield, strong growth and positive revisions momentum support valuation.
  • Five consecutive quarters of positive free cash flow enable reinvestment.

Bear says

  • Operating expenses climbed 41% YoY to $182M, pressuring margin recovery.
  • Elevated volatility and high short interest reflect investor skepticism.
  • Weak balance sheet quality raises funding and liquidity concerns.
  • Negative dividend yield signals challenges in returning capital to shareholders.
  • Expense growth may mask costs, risking a value trap scenario.
  • Loss ratio volatility underscores underwriting risk amid rapid expansion.

Investment themes with LMND

Recent IPOs -0.74%

Companies that recently went public

SNOW · PLTR · PTON
L&H Insurance +0.32%

PGR · TRV · ALL
FinTech Lending -0.02%

Financial technology companies providing loans

SOFI · COIN · FIS

Earnings Call · Q2 2025 · Mgmt. Guidance

Updated 08-04-2026neutral

Transcript signals

Bull points

  • we've talked about a 6 to 1 target ratio in the past. Historically, we've been above and below that ratio, depending on how the loss ratio and the premium growth and some other factors that impact that ratio have changed. But over the coming several year outlook, that ratio target for us is unchanged.
  • In short, our Q2 financial results were exemplary across the board. We remain very much on track with our ambitious goals for positive EBITDA by the end of next year, loss ratio tracking to target, consistently accelerating top-line growth with little change in fixed overhead expenses and favorable cash flow dynamics.
  • Enforced premium grew 29 percent to just above a billion dollars, while customer account increased by 24 percent to 2.7 million.

Bear points

  • what capital has trended at the holding company level apart from the insurance entities, just as we think about the need for potential more capital at the insurance entities to come from the holding company?
  • We estimate that there's roughly a 4% drag on that metric because of our home efforts to move more aggressively to profitability.
  • Annual dollar retention or ADR was 84 percent, flat as compared to the prior quarter, and continuing to show modest downward pressure as a result of our continuing effort to improve the profitability of our home book through targeted non-renewals. We expect ADR to normalize and resume improvement over the coming quarters.
Read full transcript analysis ›